Legis Daily

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

USA117th CongressS-1971| Senate 
| Updated: 6/8/2021
Benjamin L. Cardin

Benjamin L. Cardin

Democratic Senator

Maryland

Cosponsors (1)
Roy Blunt (Republican)

Finance Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 This bill modifies provisions relating to Medicare coverage of treatments for chronic kidney disease. Specifically, the bill expands the Medicare annual wellness visit to include chronic kidney disease screening and allows certain Medicare beneficiaries who have End Stage Renal Disease to enroll in Medicare supplemental policies. It also (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-1676
Chronic Kidney Disease Improvement in Research and Treatment Act of 2019
Jun 8, 2021
Introduced in Senate
Jun 8, 2021
Read twice and referred to the Committee on Finance.
Jun 23, 2021

Latest Companion Bill Action

HR 117-4065
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    S 116-1676
    Chronic Kidney Disease Improvement in Research and Treatment Act of 2019


  • June 8, 2021
    Introduced in Senate


  • June 8, 2021
    Read twice and referred to the Committee on Finance.


  • June 23, 2021

    Latest Companion Bill Action

    HR 117-4065
    Referred to the Subcommittee on Health.

Health

Related Bills

  • HR 117-4065: Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth facilities and institutionsHealth promotion and preventive careHealth technology, devices, suppliesMedicaidMedical researchMedical tests and diagnostic methodsMedicareMinority healthOrgan and tissue donation and transplantationState and local government operations

Chronic Kidney Disease Improvement in Research and Treatment Act of 2021

USA117th CongressS-1971| Senate 
| Updated: 6/8/2021
Chronic Kidney Disease Improvement in Research and Treatment Act of 2021 This bill modifies provisions relating to Medicare coverage of treatments for chronic kidney disease. Specifically, the bill expands the Medicare annual wellness visit to include chronic kidney disease screening and allows certain Medicare beneficiaries who have End Stage Renal Disease to enroll in Medicare supplemental policies. It also (1) provides for alternative payment methodologies for certain new drugs, biologics, and devices that are renal dialysis services; (2) revises quality measures; (3) establishes an incentive payment methodology; and (4) increases access to kidney disease education services.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline

Bill from Previous Congress

S 116-1676
Chronic Kidney Disease Improvement in Research and Treatment Act of 2019
Jun 8, 2021
Introduced in Senate
Jun 8, 2021
Read twice and referred to the Committee on Finance.
Jun 23, 2021

Latest Companion Bill Action

HR 117-4065
Referred to the Subcommittee on Health.
  • Bill from Previous Congress

    S 116-1676
    Chronic Kidney Disease Improvement in Research and Treatment Act of 2019


  • June 8, 2021
    Introduced in Senate


  • June 8, 2021
    Read twice and referred to the Committee on Finance.


  • June 23, 2021

    Latest Companion Bill Action

    HR 117-4065
    Referred to the Subcommittee on Health.
Benjamin L. Cardin

Benjamin L. Cardin

Democratic Senator

Maryland

Cosponsors (1)
Roy Blunt (Republican)

Finance Committee

Health

Related Bills

  • HR 117-4065: Chronic Kidney Disease Improvement in Research and Treatment Act of 2021
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Administrative law and regulatory proceduresCongressional oversightDepartment of Health and Human ServicesDigestive and metabolic diseasesDrug therapyGovernment studies and investigationsHealth care costs and insuranceHealth care coverage and accessHealth care qualityHealth facilities and institutionsHealth promotion and preventive careHealth technology, devices, suppliesMedicaidMedical researchMedical tests and diagnostic methodsMedicareMinority healthOrgan and tissue donation and transplantationState and local government operations